Markston International’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.49M | Sell |
11,027
-2,382
| -18% | -$281K | 1.51% | 21 |
|
|
2021
Q3 | $1.45M | Sell |
13,409
-9,638
| -42% | -$1.1M | 1.35% | 27 |
|
|
2021
Q2 | $2.6M | Sell |
23,047
-81,583
| -78% | -$9.19M | 1.58% | 22 |
|
|
2021
Q1 | $11.3M | Sell |
104,630
-2,785
| -3% | -$298K | 1.27% | 27 |
|
|
2020
Q4 | $11.5M | Sell |
107,415
-7,398
| -6% | -$711K | 1.35% | 24 |
|
|
2020
Q3 | $10.1M | Sell |
114,813
-17,650
| -13% | -$1.66M | 1.28% | 25 |
|
|
2020
Q2 | $13M | Sell |
132,463
-1,960
| -1% | -$173K | 1.53% | 21 |
|
|
2020
Q1 | $10.2M | Sell |
134,423
-251
| -0.2% | -$21.4K | 1.42% | 23 |
|
|
2019
Q4 | $11.9M | Sell |
134,674
-7,680
| -5% | -$638K | 1.24% | 29 |
|
|
2019
Q3 | $10.8M | Buy |
142,354
+4,886
| +4% | +$335K | 1.21% | 31 |
|
|
2019
Q2 | $10M | Buy |
137,468
+13,158
| +11% | +$1.03M | 1.16% | 32 |
|
|
2019
Q1 | $10M | Buy |
124,310
+1,272
| +1% | +$104K | 1.17% | 32 |
|
|
2018
Q4 | $11.3M | Buy |
123,038
+435
| +0.4% | +$38.3K | 1.46% | 24 |
|
|
2018
Q3 | $11.6M | Sell |
122,603
-1,535
| -1% | -$146K | 1.24% | 29 |
|
|
2018
Q2 | $11.4M | Sell |
124,138
-193
| -0.2% | -$18.8K | 1.23% | 30 |
|
|
2018
Q1 | $11.8M | Sell |
124,331
-15,356
| -11% | -$1.69M | 1.27% | 28 |
|
|
2017
Q4 | $13.5M | Sell |
139,687
-12,997
| -9% | -$1.22M | 1.4% | 24 |
|
|
2017
Q3 | $13.6M | Sell |
152,684
-24,352
| -14% | -$1.85M | 1.39% | 23 |
|
|
2017
Q2 | $12.8M | Sell |
177,036
-30,021
| -14% | -$2.02M | 1.25% | 28 |
|
|
2017
Q1 | $13.5M | Sell |
207,057
-9,497
| -4% | -$597K | 1.32% | 25 |
|
|
2016
Q4 | $13.6M | Sell |
216,554
-12,969
| -6% | -$792K | 1.29% | 26 |
|
|
2016
Q3 | $14.5M | Sell |
229,523
-7,813
| -3% | -$506K | 1.35% | 20 |
|
|
2016
Q2 | $14.7M | Sell |
237,336
-6,344
| -3% | -$387K | 1.38% | 21 |
|
|
2016
Q1 | $13.9M | Buy |
243,680
+36,018
| +17% | +$2.01M | 1.32% | 22 |
|
|
2015
Q4 | $12.3M | Buy |
207,662
+69,600
| +50% | +$4.01M | 1.05% | 32 |
|
|
2015
Q3 | $7.51M | Sell |
138,062
-9,401
| -6% | -$612K | 0.66% | 61 |
|
|
2015
Q2 | $9.91M | Sell |
147,463
-9,450
| -6% | -$617K | 0.73% | 56 |
|
|
2015
Q1 | $9.19M | Sell |
156,913
-6,212
| -4% | -$375K | 0.62% | 64 |
|
|
2014
Q4 | $10.7M | Sell |
163,125
-9,680
| -6% | -$610K | 0.66% | 61 |
|
|
2014
Q3 | $9.98M | Sell |
172,805
-1,621
| -0.9% | -$90K | 0.61% | 68 |
|
|
2014
Q2 | $9.84M | Sell |
174,426
-985
| -0.6% | -$51.7K | 0.6% | 67 |
|
|
2014
Q1 | $9.02M | Sell |
175,411
-100
| -0.1% | -$5.05K | 0.57% | 68 |
|
|
2013
Q4 | $9.27M | Sell |
175,511
-5,100
| -3% | -$251K | 0.59% | 67 |
|
|
2013
Q3 | $8.08M | Sell |
180,611
-9,150
| -5% | -$406K | 0.54% | 69 |
|
|
2013
Q2 | $7.84M | Buy |
+189,761
| New | +$8.3M | 0.51% | 72 |
|
Other funds holding ABBV
Markston International's ABBV Position: Q4 2021 in Review
Markston International reduced its AbbVie (ABBV) stake by 18% in Q4 2021, selling an estimated $281K and leaving 11,027 shares worth $1.49M. The position accounts for 1.51% of the portfolio, ranked #21.
Markston International first reported a position in ABBV in Q2 2013 and has held it in 35 quarters since. The position peaked at $14.7M in Q2 2016. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.
- Markston International held 11,027 shares of AbbVie worth $1.49M as of Q4 2021.
- Markston International sold 2,382 AbbVie shares in Q4 2021, an estimated $281K.
- AbbVie made up 1.51% of Markston International's portfolio in Q4 2021, its #21 holding.
- Markston International first reported a position in AbbVie in Q2 2013 and has held it in 35 quarters since.
- Markston International's AbbVie position peaked at $14.7M in Q2 2016.
- 2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.
Based on Markston International's 13F filing for Q4 2021, filed 21 Jan 2022.